Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study
Publication
, Conference
Kowdley, KV; Gordon, SC; Reddy, KR; Rossaro, L; Bernstein, D; An, D; Svarovskaia, E; Hyland, RH; Pang, P; Symonds, WT; McHutchison, JG ...
Published in: GASTROENTEROLOGY
May 1, 2014
Duke Scholars
Published In
GASTROENTEROLOGY
EISSN
1528-0012
ISSN
0016-5085
Publication Date
May 1, 2014
Volume
146
Issue
5
Start / End Page
S926 / S926
Location
Chicago, IL
Publisher
W B SAUNDERS CO-ELSEVIER INC
Conference Name
55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW)
Related Subject Headings
- Gastroenterology & Hepatology
- 3210 Nutrition and dietetics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kowdley, K. V., Gordon, S. C., Reddy, K. R., Rossaro, L., Bernstein, D., An, D., … Fried, M. W. (2014). Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study. In GASTROENTEROLOGY (Vol. 146, pp. S926–S926). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC.
Kowdley, Kris V., Stuart C. Gordon, K Rajender Reddy, Lorenzo Rossaro, David Bernstein, Di An, Evguenia Svarovskaia, et al. “Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study.” In GASTROENTEROLOGY, 146:S926–S926. W B SAUNDERS CO-ELSEVIER INC, 2014.
Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein D, An D, et al. Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study. In: GASTROENTEROLOGY. W B SAUNDERS CO-ELSEVIER INC; 2014. p. S926–S926.
Kowdley, Kris V., et al. “Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study.” GASTROENTEROLOGY, vol. 146, no. 5, W B SAUNDERS CO-ELSEVIER INC, 2014, pp. S926–S926.
Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein D, An D, Svarovskaia E, Hyland RH, Pang P, Symonds WT, McHutchison JG, Muir AJ, Pockros PJ, Pound D, Fried MW. Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study. GASTROENTEROLOGY. W B SAUNDERS CO-ELSEVIER INC; 2014. p. S926–S926.
Published In
GASTROENTEROLOGY
EISSN
1528-0012
ISSN
0016-5085
Publication Date
May 1, 2014
Volume
146
Issue
5
Start / End Page
S926 / S926
Location
Chicago, IL
Publisher
W B SAUNDERS CO-ELSEVIER INC
Conference Name
55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW)
Related Subject Headings
- Gastroenterology & Hepatology
- 3210 Nutrition and dietetics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1109 Neurosciences
- 1103 Clinical Sciences